CellCAN Overview
- Headquarters
- Ca
- Website
- cellcan.com
- Industry
- Research Services
- Employees
- 6
- Founded
- 2014
- Funding
- ,
- Company Email
- Available in AeroLeads
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
About CellCAN
The field of regenerative medicine and cell and gene therapy is rapidly evolving thanks to the excellence in fundamental research and new front-line technologies. Collaboration and information sharing between researchers, regulators, funding agencies and industry is essential and requires a streamlined approach to conducting cell and gene therapy clinical trials. This requires a central hub of information for better implementation and an overall improvement to patient care.This is why CellCAN was created in 2014. Our vision is that cell and gene therapy manufacturing in Canada should operate under a common seal of quality to increase capacity and rapidly and effectively migrate innovative treatment concepts into standard clinical practice.
CellCAN Contact Details
- People in AeroLeads
- 1
- With contact data
- 1
- Email contacts
- 1
- 100.0% coverage
CellCAN Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Denis-Claude Roy | Director, Hematology-oncology & Cell Therapy University Institute, Hopital Maisonneuve-rosemont | Montreal, Quebec, Canada |
Email
|
Compare Similar Companies to CellCAN
CCRM
Biotechnology Research
OmniaBio
Biotechnology Research
C3i
Biotechnology
Acuitas Therapeutics
Biotechnology
adMare BioInnovations
Biotechnology Research
Virica Biotech
Biotechnology Research
Morphocell Technologies
Biotechnology Research
Notch Therapeutics
Biotechnology Research
ExCellThera
Biotechnology Research
CATTI
E-Learning Providers